Cargando...
Downsizing and Prostate Cancer
In the treatment of prostatic carcinoma, neoadjuvant androgen deprivation therapy has been shown to confer several clinical and quality-of-life benefits. Compared with the luteinizing hormone-releasing hormone agonists, gonadotropin-releasing hormone antagonists can achieve castrate levels of testos...
Gardado en:
Autor Principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado: |
MedReviews, LLC
2004
|
Assuntos: | |
Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1472890/ https://ncbi.nlm.nih.gov/pubmed/16985932 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|